Novo Nordisk Articles

THROMBOPOIETIN CLONED IN MAJOR BREAKTHROUGH

20 June 1994

BIOPHARMACEUTICALS MARKET GROWING FAST

13 June 1994

NOVO NORDISK GAINS CHINA LAND-USE RIGHTS

6 June 1994

NOVO NORDISK APPOINTMENT

30 May 1994

NOVO NORDISK APPOINTMENTS

23 May 1994

NOVO NORDISK CONFIDENT, DESPITE PROFITS DOWNTURN

23 May 1994

B-MS TO MARKET GLUCOPHAGE IN USA

9 May 1994

NOVO NORDISK APPOINTMENT

11 April 1994

NEW THERAPIES FOR MULTIPLE SCLEROSIS

4 April 1994

NOVO NORDISK IN RESEARCH DEAL

21 March 1994

GENENTECH'S hGH APPROVED IN USA

21 March 1994

NOVO NORDISK'S RESULTS FOR 1993 AS EXPECTED

14 March 1994

SWEDISH PHARMA MARKET GROWTH SLOWDOWN

28 February 1994

ROUND-UP OF 1993'S NEW CHEMICAL ENTITIES

31 January 1994

FRAGMIN APPROVABLE, SAYS FDA

24 January 1994

CHANGES AT NOVO NORDISK MANAGEMENT

10 January 1994

1992 SEES SMALLER COMPANY MERGERS

10 January 1994

SANKYO-DEVELOPED DRUGS SPUR GROWTH

10 January 1994

NINE-MONTH PROFITS UP 4% AT NOVO NORDISK

15 November 1993

NOVO NORDISK LAUNCH

25 October 1993

NOVO NORDISK TO POST3rd QTR "SUBSTANTIAL RISE"

25 October 1993

US BIOTECH PRODUCTS IN R&D (Cont'd from last issue)

4 October 1993

PMA WARNING ON FUTURE OF BIOTECHNOLOGY

27 September 1993

NOVO NORDISK TO BUY B-MS' ITALIAN UNIT

20 September 1993

NOVO NORDISK IN R&D DEAL WITH ANERGEN

6 September 1993

EARNINGS FALL AT NOVO NORDISK

16 August 1993

UK INDUSTRY CODE OF PRACTICE REVIEW

19 July 1993

NOVO NORDISK WARNS ON EARNINGS

12 July 1993

EURO DRUG POLICY "MUST DEREGULATE"

31 May 1993

NOVO NORDISK 1st QTR AS EXPECTED

17 May 1993

NOVO NORDISK EXPANDING ITS FOCUS

26 April 1993

ABBOTT ACHIEVES RECORD SALES

19 April 1993

SWEDEN'S PHARMA MARKET IN 1992

5 April 1993

NOVO NORDISK RESEARCH SUPPORT

5 April 1993

WORLD ENDOCRINE MARKET AND FORECASTS

29 March 1993

GENENTECH FILES COMPLAINT

22 March 1993

NOVO NORDISK TAX CUTS BENEFIT

22 March 1993

PHARMACEUTICAL DESIGN: EPITOPE SELECTION

15 March 1993

SIGNIFICANT MOVES BY PHARMA COS IN FT 500

1 March 1993

MILES LABS AND RHONE-POULENC REACH AGREEMENT

15 February 1993

UK: NOVO INSULIN PEN INJECTOR LAUNCHED

15 February 1993

NOVO NORDISK NASAL INSULIN DELAYS

25 January 1993

FORTHCOMING MEETINGS

14 December 1992

NOVO NORDISK GROWTH PROSPECTS

12 October 1992

NOVO NORDISK R&D PLANT

5 October 1992

1st QTR PROFITS JUMP AT NOVO NORDISK

18 May 1992

SWEDEN'S PHARMA MARKET IN 1991

11 May 1992

PROJECT REVIEW FROM NOVO NORDISK

27 April 1992

NOVO NORDISK TO INVEST IN SPAIN

20 April 1992

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

DEPRESSION: THE COST TO SOCIETY

6 April 1992

DEPRESSION: THE COST TO SOCIETY

6 April 1992

NOVO REPORTS 28% PRETAX PROFIT JUMP

16 March 1992

NEW SALES DIRECTOR AT NOVO NORDISK PHARMA UK

27 January 1992

FEWER ACQUISITIONS AND MERGERS IN 1991

6 January 1992

Novo Nordisk ups 2008 guidance